Clinical Trial

Exploring the Patterns of Sleep Disordered Breathing in Systemic Sclerosis Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease characterized by progressive fibrosis of the skin and internal organs. Fatigue, non-restorative sleep, and poor sleep quality are frequently reported among patients with SSc, yet these symptoms remain under-recognized and under-investigated in clinical practice. Despite growing awareness of the burden of sleep-related symptoms, there is a significant lack of objective data regarding sleep disturbances in this population, particularly those assessed using polysomnography (PSG).
Trial Details
NCT Number NCT07175246
Lead Sponsor Assiut University
Conditions Systemic Sclerosis, Sleep-Disordered Breathing
Enrollment 30 participants
Start Date 2025-09-20
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-16